Osaic Holdings
IBRX icon

Osaic Holdings’s ImmunityBio IBRX Stock Holding History

Osaic Holdings’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.67M Buy
875,621
+774,305
+764% +$5.86M 0.01% 1223
2026
Q1 		$777K Sell
101,316
-123,812
-55% -$848K ﹤0.01% 2942
2025
Q4 		$446K Sell
225,128
-2,364
-1% -$5.36K ﹤0.01% 3439
2025
Q3 		$534K Buy
227,492
+25,733
+13% +$66.3K ﹤0.01% 3377
2025
Q2 		$533K Buy
201,759
+49,234
+32% +$132K ﹤0.01% 3075
2025
Q1 		$459K Buy
152,525
+54,978
+56% +$167K ﹤0.01% 2953
2024
Q4 		$250K Sell
97,547
-5,645
-5% -$23.5K ﹤0.01% 3406
2024
Q3 		$384K Buy
103,192
+28,338
+38% +$131K ﹤0.01% 3112
2024
Q2 		$473K Buy
74,854
+31,697
+73% +$209K ﹤0.01% 2821
2024
Q1 		$232K Buy
43,157
+12,609
+41% +$57.1K ﹤0.01% 3564
2023
Q4 		$153K Buy
30,548
+1,843
+6% +$5.78K ﹤0.01% 4137
2023
Q3 		$48.5K Buy
28,705
+15,827
+123% +$31.8K ﹤0.01% 5027
2023
Q2 		$35.8K Sell
12,878
-10,635
-45% -$30.1K ﹤0.01% 5160
2023
Q1 		$42.8K Sell
23,513
-2,556
-10% -$7.95K ﹤0.01% 5058
2022
Q4 		$133K Sell
26,069
-9,213
-26% -$50.6K ﹤0.01% 4208
2022
Q3 		$176K Buy
35,282
+2,763
+8% +$12.6K ﹤0.01% 3872
2022
Q2 		$122K Buy
32,519
+20,128
+162% +$80.8K ﹤0.01% 4248
2022
Q1 		$69K Buy
12,391
+754
+6% +$4.63K ﹤0.01% 4853
2021
Q4 		$71K Sell
11,637
-20,184
-63% -$152K ﹤0.01% 4872
2021
Q3 		$309K Buy
31,821
+18,783
+144% +$207K ﹤0.01% 3519
2021
Q2 		$186K Buy
13,038
+8,768
+205% +$145K ﹤0.01% 3911
2021
Q1 		$102K Buy
4,270
+2,420
+131% +$62.7K ﹤0.01% 4322
2020
Q4 		$24K Sell
1,850
-7,650
-81% -$73.6K ﹤0.01% 5044
2020
Q3 		$67K Buy
9,500
+8,520
+869% +$84.9K ﹤0.01% 4102
2020
Q2 		$12K Buy
980
+382
+64% +$2.16K ﹤0.01% 5090
2020
Q1 		$2K Buy
+598
New +$3K ﹤0.01% 5684

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's IBRX Position: Q2 2026 in Review

Osaic Holdings increased its ImmunityBio (IBRX) stake by 764% in Q2 2026, buying an estimated $5.86M and bringing the position to 875,621 shares worth $7.67M. The position accounts for 0.01% of the portfolio, ranked #1223.

Osaic Holdings first reported a position in IBRX in Q1 2020 and has held it in 26 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Osaic Holdings held 875,621 shares of ImmunityBio worth $7.67M as of Q2 2026.
  • Osaic Holdings bought 774,305 ImmunityBio shares in Q2 2026, an estimated $5.86M.
  • ImmunityBio made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1223 holding.
  • Osaic Holdings first reported a position in ImmunityBio in Q1 2020 and has held it in 26 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.